IP Library › Granted Patent US 9,481,756
Granted Patent B2
US 9,481,756 · App. 13/635,023 · Granted Nov 1, 2016

Curable composition

Inventor: Mitsuhiro Kaneta (Tokyo, JP)
Assignee: ThreeBond Fine Chemical Co., Ltd.
C08F299/028
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,481,756
App. No.
13/635,023
Granted
Nov 1, 2016
Kind
B2
Abstract

The present invention relates to a curable composition including: (a) at least one compound having at least one (meth)acrylic functional group in the molecule thereof, which is selected from a (meth)acrylic monomer and a (meth)acrylic oligomer; (b) an organic peroxide; (c) an o-benzoic sulfimide; and (d) an oxazoline compound, in which the component (d) is contained in an amount of 0.005 to 10 parts by mass based on 100 parts by weight of the component (a).

Claims (13)

1. A curable composition comprising:

(a) a (meth)acryl functional group-containing component including the following compounds (a-1) and (a-2):

(a-1) a compound having an aromatic ring skeleton and having two or more (meth)acryloyl groups in the molecule thereof; and

(a-2) at least one selected from the group consisting of 2-hydroxyethyl (meth)acrylate, 2-hydroxypropyl (meth)acrylate, 2-hydroxybutyl (meth)acrylate, tetrahydrofurfuryl (meth)acrylate, caprolactone-modified tetrahydrofurfuryl (meth)acrylate, cyclohexyl (meth)acrylate, dicyclopentanyl (meth)acrylate, isobornyl (meth)acrylate, dicyclopentenyl diacrylate, and ethylene oxide-modified dicyclopentenyl di(meth)acrylate;

(b) an organic peroxide;

(c) an o-benzoic sulfimide; and

(d) an oxazoline compound,

wherein the component (d) is contained in an amount of 0.1 to 5 parts by weight based on 100 parts by weight of the component (a).

2. The curable composition according to claim 1 , wherein the component (b) is contained in an amount of 0.005 to 5 parts by weight, and the component (c) is contained in an amount of 0.05 to 10 parts by weight, based on 100 parts by weight of the component (a).

3. The curable composition according to claim 1 , wherein the component (d) is a compound having two or less oxazoline groups in the molecule thereof.

4. The curable composition according to claim 1 , wherein the component (d) is a compound represented by the following formula (I):

in which R1 is selected from hydrogen, a substituted or unsubstituted alkyl group having a carbon number of 1 to 6, a cyclic alkyl group and a halogen, and one R1 or a plurality of R1 may be present and may be the same as or different from one another; and each of R2 and R3 is selected from hydrogen, a substituted or unsubstituted alkyl group having a carbon number of 1 to 10, a cyclic alkyl group, an aromatic heterocyclic ring, an aliphatic heterocyclic ring and a halogen and may be the same as or different from one another.

5. The curable composition according to claim 1 , further having curability imparted by at least one energy selected from heating and active light irradiation.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 5, 2014
From: THREE BOND CO., LTD.
To: THREEBOND FINE CHEMICAL CO., LTD.
Reel/Frame 032816/0860 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 14, 2012
From: KANETA, MITSUHIRO
To: THREE BOND CO., LTD.
Reel/Frame 028974/0060 →
Priority Claims (1)
JP 2010-062204 · Mar 18, 2010 · national
Continuity (1)
Related Publication 20130005854A1 · Jan 3, 2013